ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 726217 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 726217; 2) Community: the network communities that were significantly associated with the response to NSC 726217; 3) Molecule: the relationships between components within communities and NSC 726217; 4) MDR: the compounds that were significantly associated with the NSC 726217.

NSC Compound Enrichment Correlation
NSC 746608 Null 0.0348993771550531 0.33014213
NSC 753665 Null 0.0348993771550531 0.42164219
NSC 756416 SB-220025-A 0.0348993771550531 -0.10358533
NSC 756468 SB-725317 0.0348993771550531 0.36823708
NSC 726718 3-(Benzothiazol-6-ylamino)-7-chloro-8-methyl-1,1,-dioxo-4H-1 ,5,2-benzodithiazepin-4-ylideneacetic acid 0.035202825328704 0.24612937
NSC 726863 6-[4-(1-cyclohexenyl)-1,3-butadiyn-1-yl]-2(2H)-pyranone 0.035202825328704 0.26040399
NSC 727985 NSC 708781 incorporated in micelles, 0.55% (w/w) of drug 0.035202825328704 0.4827075
NSC 730460 16-[4-{(3-Imidazol-1-yl)propoxy}-3-methoxybenzylidene]-3b-py rrolidino-5-androsten-17b-YL acetate 0.035202825328704 0.28218822
NSC 732112 6-(O-ethyl-2?-diethylamino)-7-(p-methoxycinnamoyl)-3-methyl- benzofuran-2-carboxylic acid ethyl ester hydrochloride 0.035202825328704 0.10602064
NSC 740386 3,7-di(trifluoromethyl)-2-furoylquioxaline 1,4-dioxide 0.035202825328704 0.12461023
Total:83  Current:60    [First] [Prev] [Next] [Last]